PNC Financial Services Group
NVCT icon

PNC Financial Services Group’s Nuvectis Pharma NVCT Stock Holding History

PNC Financial Services Group’s Portfolio NVCT Stock Details NVCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$515 Buy
28
+5
+22% +$56 ﹤0.01% 4982
2026
Q1 		$178 Hold
23
– – ﹤0.01% 5045
2025
Q4 		$174 Sell
23
-32
-58% -$209 ﹤0.01% 4994
2025
Q3 		$331 Buy
+55
New +$378 ﹤0.01% 4874

Other funds holding NVCT

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OCM
Occam Crest Management Darien, Connecticut $193M AUM 233.09% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
BWP
Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return

PNC Financial Services Group's NVCT Position: Q2 2026 in Review

PNC Financial Services Group increased its Nuvectis Pharma (NVCT) stake by 22% in Q2 2026, buying an estimated $56 and bringing the position to 28 shares worth $515. The position accounts for ﹤0.01% of the portfolio, ranked #4982.

PNC Financial Services Group first reported a position in NVCT in Q3 2025 and has held it in 4 quarters since. 83 funds tracked by Wall St. Rank hold NVCT as of Q2 2026.

  • PNC Financial Services Group held 28 shares of Nuvectis Pharma worth $515 as of Q2 2026.
  • PNC Financial Services Group bought 5 Nuvectis Pharma shares in Q2 2026, an estimated $56.
  • Nuvectis Pharma made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4982 holding.
  • PNC Financial Services Group first reported a position in Nuvectis Pharma in Q3 2025 and has held it in 4 quarters since.
  • 83 funds tracked by Wall St. Rank held Nuvectis Pharma as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.